International workgroup issues additional guidance on how to manage patients who carry inherited CHEK2 gene mutations that put them at a higher risk for cancer.

Vanderbilt University School of Medicine Academy for Excellence in Clinical Medicine (AECM) has selected 25 new members.

Immunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastatic breast cancer. Which patients will benefit the most, however, remains unclear; current biomarkers such as PD-L1 that are used to predict response are mediocre at best.

Ken Lau, professor of cell and developmental biology, has been selected to receive a one-year research award from the Stanley Cohen Innovation Fund.

Human research will be more equitable, inclusive and stronger if the people who are participants in studies also help plan and guide the direction of those studies.